Homologous overexpression of RfaH in E. coli K4 improves the production of chondroitin-like capsular polysaccharide.

scientific article published on 9 May 2013

Homologous overexpression of RfaH in E. coli K4 improves the production of chondroitin-like capsular polysaccharide. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043842056
P356DOI10.1186/1475-2859-12-46
P932PMC publication ID3673904
P698PubMed publication ID23659469
P5875ResearchGate publication ID236673675

P50authorChiara SchiraldiQ57010103
P2093author name stringDonatella Cimini
Alessandro Ruggiero
Mario De Rosa
Elisabetta Carlino
P2860cites workPromoter region of the Escherichia coli O7-specific lipopolysaccharide gene cluster: structural and functional characterization of an upstream untranslated mRNA sequenceQ24522173
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Advantages in the analysis of UDP-sugars by capillary electrophoresis-comparison of the conventional HPLC method with two new capillary electrophoretic micro-proceduresQ32059322
Proteomics analysis of Lactobacillus casei Zhang, a new probiotic bacterium isolated from traditional home-made koumiss in Inner Mongolia of ChinaQ33464798
Structure, assembly and regulation of expression of capsules in Escherichia coliQ33592585
Molecular cloning and characterization of chondroitin polymerase from Escherichia coli strain K4.Q34123060
Structural interactions in chondroitin 4-sulfate mediated adherence of Plasmodium falciparum infected erythrocytes in human placenta during pregnancy-associated malariaQ37104991
Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromoleculeQ37951364
Production of glucuronic acid-based polysaccharides by microbial fermentation for biomedical applications.Q37962487
Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrowQ37990761
Regulation of the Escherichia coli K5 capsule gene cluster: evidence for the roles of H-NS, BipA, and integration host factor in regulation of group 2 capsule gene clusters in pathogenic E. coliQ39539212
Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli.Q39655823
The Escherichia coli gapA gene is transcribed by the vegetative RNA polymerase holoenzyme E sigma 70 and by the heat shock RNA polymerase E sigma 32.Q39930448
Common organization of gene clusters for production of different capsular polysaccharides (K antigens) in Escherichia coliQ39952403
The effect of gelatin-chondroitin sulfate-hyaluronic acid skin substitute on wound healing in SCID mice.Q40298058
High cell density cultivation of Escherichia coli K4 in a microfiltration bioreactor: a step towards improvement of chondroitin precursor productionQ42032399
Global metabolite analysis: the influence of extraction methodology on metabolome profiles of Escherichia coliQ44308011
Optimization of medium components for high-molecular-weight hyaluronic acid production by Streptococcus sp. ID9102 via a statistical approach.Q45922522
An efficient process for production and purification of hyaluronic acid from Streptococcus equi subsp. zooepidemicusQ46934655
Regulation of the Escherichia coli K5 capsule gene cluster by transcription antiterminationQ48048999
Regulation of Escherichia coli K5 capsular polysaccharide expression: evidence for involvement of RfaH in the expression of group II capsulesQ48077999
Molecular analysis of the Escherichia coli K5 kps locus: identification and characterization of an inner-membrane capsular polysaccharide transport systemQ48250084
Improved fructosylated chondroitin production by kfoC overexpression in E. coli K4.Q50045964
Raised serum chondroitin sulfate epitope level in ovarian epithelial cancer.Q51140217
Application of a 22L scale membrane bioreactor and cross-flow ultrafiltration to obtain purified chondroitin.Q54335888
A microbiological-chemical strategy to produce chondroitin sulfate A,C.Q54361104
Production of capsular polysaccharide from Escherichia coli K4 for biotechnological applications.Q54397883
Anti-arthritic action mechanisms of natural chondroitin sulfate in human articular chondrocytes and synovial fibroblastsQ83069860
High-performance CE of Escherichia coli K4 cell surface polysaccharidesQ84950953
P921main subjectEscherichia coliQ25419
polysaccharideQ134219
overexpressionQ61643320
P304page(s)46
P577publication date2013-05-09
P1433published inMicrobial Cell FactoriesQ15766995
P1476titleHomologous overexpression of RfaH in E. coli K4 improves the production of chondroitin-like capsular polysaccharide
P478volume12

Reverse relations

cites work (P2860)
Q38983228A combined fermentative-chemical approach for the scalable production of pure E. coli monophosphoryl lipid A.
Q51095298Corynebacterium glutamicum for Sustainable Bioproduction: From Metabolic Physiology to Systems Metabolic Engineering.
Q37699497Engineering S. equi subsp. zooepidemicus towards concurrent production of hyaluronic acid and chondroitin biopolymers of biomedical interest
Q40759761Engineering a branch of the UDP-precursor biosynthesis pathway enhances the production of capsular polysaccharide in Escherichia coli O5:K4:H4.
Q88357945Enhancing fructosylated chondroitin production in Escherichia coli K4 by balancing the UDP-precursors
Q47860134Expression of chondroitin-4-O-sulfotransferase in Escherichia coli and Pichia pastoris
Q35987516Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering
Q54296252IS2-mediated overexpression of kfoC in E. coli K4 increases chondroitin-like capsular polysaccharide production.
Q52649425KfoE encodes a fructosyltransferase involved in capsular polysaccharide biosynthesis in Escherichia coli K4.
Q26865784Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules
Q42320693New insight into chondroitin and heparosan-like capsular polysaccharide synthesis by profiling of the nucleotide sugar precursors
Q98237551Production and purification of higher molecular weight chondroitin by metabolically engineered Escherichia coli K4 strains
Q53373309Production of chondroitin in metabolically engineered E. coli.
Q34459318The re-emergence of natural products for drug discovery in the genomics era.

Search more.